Concepedia
Statistics
Publications
8
Citations
533
H-Index
Active since
2006
Affiliations
University of Nottingham(Current)
Nottingham City Hospital
Nottingham University Hospitals NHS Trust
Royal Derby Hospital
Addenbrooke's Hospital
Phil Rolland is an author at University of Nottingham specializing in medicine, oncology, and molecular oncology.
Publications per year
2006–2019
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease
Phil Rolland, Zahra Madjd, Lindy G. Durrant et al. · Endocrine Related Cancer · 2007 · 127 citations · Full text
Medicine, Molecular Biology, Oncology +17
Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
Timothy J. Duncan, Ahmad Al‐Attar, Phil Rolland et al. · Clinical Cancer Research · 2008 · 111 citations · Full text
Medicine, Gynecology, Oncology +17
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
Roger McGilvray, Robert A. Eagle, Phil Rolland et al. · International Journal of Cancer · 2010 · 85 citations · Full text
Medicine, Immunology, Oncology +13
Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer
Phil Rolland, Suha Deen, Ian Scott et al. · Clinical Cancer Research · 2007 · 61 citations
Medicine, Oncology, Pathology +17
The p53 positive Bcl‐2 negative phenotype is an independent marker of prognosis in breast cancer
Phil Rolland, Ian Spendlove, Zahra Madjid et al. · International Journal of Cancer · 2006 · 53 citations
Medicine, Oncology, Breast Oncology +15
1–5 of 8